Results of further analysis revealed a dramatic increase in IGF2BP2 expression in metastatic HNSCC tumor cells compared with primary HNSCC tumor cells (Figure 1e). This evidence concerns the gene IGF2BP2 and head and neck squamous cell carcinoma.